An Evaluation of the Sensitivity and Specificity of Three COVID-19 Rapid Immunochromatographic Test Kits Compared to

S Bani1, Ebenezer K Amakye1, Shanti Akomea1

  • 1Department of Biomedical Laboratory Sciences, School of Allied Health Sciences, University for Development Studies, Tamale, GHA.

Cureus
|July 29, 2024
PubMed

Insights

The DG Rapid and SD Rapid COVID-19 antigen tests show high diagnostic accuracy, making them reliable alternatives to rRT-PCR, especially in resource-limited settings like Ghana.

Area of Science:

  • Virology
  • Diagnostic Testing
  • Public Health

Background:

  • The COVID-19 pandemic strains global healthcare systems.
  • There is a critical need for accessible diagnostic alternatives to RT-PCR, particularly in resource-limited regions.
  • Ghana faces challenges with current COVID-19 diagnostic methods.

Purpose of the Study:

  • To evaluate the diagnostic performance of three rapid immunochromatographic antigen test kits for COVID-19.
  • To compare the sensitivity and specificity of DG Rapid, SD Rapid, and SS Rapid kits against the gold standard rRT-PCR.
  • To assess the utility of these rapid tests in resource-limited settings.

Main Methods:

  • Assessed three COVID-19 rapid antigen test kits (DG Rapid, SD Rapid, SS Rapid).
  • Compared test kit performance against real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) using 75 archived nasopharyngeal samples.
  • Calculated sensitivity, specificity, and Cohen's kappa for each kit.

Main Results:

  • All tested kits demonstrated 100% specificity.
  • DG Rapid showed 79% sensitivity and excellent agreement with rRT-PCR (kappa=0.79).
  • SD Rapid showed 74% sensitivity and good agreement (kappa=0.73), while SS Rapid showed 50% sensitivity (kappa=0.50).
  • Higher sensitivity was observed for samples with cycle threshold (Ct) values <29.99.

Conclusions:

  • DG Rapid and SD Rapid kits are effective and reliable alternatives to rRT-PCR for SARS-CoV-2 detection.
  • These rapid tests offer a viable solution for COVID-19 diagnosis in resource-limited settings like Ghana.
  • The study supports the use of these antigen tests for accessible and rapid COVID-19 screening.